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A B S T R A C T
Background: Resting-state functional magnetic resonance imaging (fMRI) studies have demonstrated that basal
ganglia functional connectivity is altered in Parkinson’s disease (PD) as compared to healthy controls. However,
such functional connectivity alterations have not been related to the dopaminergic deficits that occurs in PD over
time.
Objectives: To examine whether functional connectivity impairments are correlated with dopaminergic deficits
across basal ganglia subdivisions in patients with PD both cross-sectionally and longitudinally.
Methods: We assessed resting-state functional connectivity of basal ganglia subdivisions and dopamine trans-
porter density using 11C-PE2I PET in thirty-four PD patients at baseline. Of these, twenty PD patients were
rescanned after 19.9 ± 3.8 months. A seed-based approach was used to analyze resting-state fMRI data. 11C-
PE2I binding potential (BPND) was calculated for each participant. PD patients were assessed for disease severity.
Results: At baseline, PD patients with greater dopaminergic deficits, as measured with 11C-PE2I PET, showed
larger decreases in posterior putamen functional connectivity with the midbrain and pallidum. Reduced func-
tional connectivity of the posterior putamen with the thalamus, midbrain, supplementary motor area and sen-
sorimotor cortex over time were significantly associated with changes in DAT density over the same period.
Furthermore, increased motor disability was associated with lower intraregional functional connectivity of the
posterior putamen.
Conclusions: Our findings suggest that basal ganglia functional connectivity is related to integrity of dopami-
nergic system in patients with PD. Application of resting-state fMRI in a large cohort and longitudinal scanning
may be a powerful tool for assessing underlying PD pathology and its progression.
1. Introduction
Parkinson’s disease (PD) is characterised by progressive loss of do-
paminergic neurons in the substantia nigra and subsequent dysfunction
of dopamine neurotransmission in the striatum (Nurmi et al., 2001;
Eshuis et al., 2006). The presynaptic dopamine transporter (DAT) is a
plasma membrane transporter that is localised exclusively in dopamine
neurones (Piccini, 2003). Hence, DAT availability measured with DAT-
specific radioligands and Positron Emission Tomography (PET) is one
measure of nigrostriatal dopaminergic integrity (Shih et al., 2006;
Pavese and Brooks, 2009). Previous longitudinal studies have demon-
strated an annualized rate of reduction in striatal DAT binding of ap-
proximately 6–13% in patients with PD compared with 0–2.5% in
healthy controls (Nurmi et al., 2000; Marek et al., 2001; Parkinson
Study, 2002). The reduction in striatal DAT binding correlates with
increasing disability in patients with PD (Seibyl et al., 1995; Li et al.,
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Resting-state functional magnetic resonance imaging (fMRI) offers a
means of assessing the status of functional networks within the brain
without the confounding influence of task performance (Fox and
Greicius, 2010). It has been demonstrated that functional changes
within the basal ganglia network can differentiate patients with PD
from healthy controls (Szewczyk-Krolikowski et al., 2014), and are
responsible for the cardinal motor features of PD (Wu et al., 2012).
Hacker et al. (2012) reported lower striatal functional connectivity with
the thalamus, midbrain, pons and cerebellum in patients with PD. An-
other study using a more spatially refined analysis found reduced
functional connectivity between the posterior putamen and the sen-
sorimotor cortex while functional connectivity was increased between
the anterior putamen and the inferior parietal cortex (Helmich et al.,
2010). It has been shown that functional connectivity in PD improves
across striatal subdivisions under regular dopaminergic replacement
therapy (Bell et al., 2015), suggesting that striatal functional con-
nectivity is dependent on the integrity of dopaminergic system
(Surmeier et al., 2010). For the substantia nigra, it was found that
functional connectivity is decreased to the putamen in PD patients
compared to healthy controls (Ellmore et al., 2013).
There are few studies assessing longitudinal changes in resting-state
functional connectivity in PD patients (Olde Dubbelink et al., 2014;
Manza et al., 2016). Olde Dubbelink et al. (2014) reported a gradual
loss of global resting-state functional connectivity in PD, mainly in
sensorimotor cortex, over the course of three years, which was modestly
related to motor deficits (Olde Dubbelink et al., 2014). However, it is
unclear how changes in resting-state functional connectivity are related
to dopaminergic decline in patients with PD over time.
The primary aim of this study was to examine whether functional
connectivity impairments are correlated with dopaminergic deficits
across basal ganglia subdivisions in patients with PD both cross-sec-
tionally and longitudinally. Here, we used resting-state fMRI to assess
functional connectivity in thirty-four PD patients and fifteen age-mat-
ched healthy controls. To estimate DAT binding we used 11C-PE2I PET,
a highly specific radioligand which has been shown to be closely as-
sociated with PD motor severity and progression (Li et al., 2017). We
hypothesized that longitudinal changes in resting-state functional
connectivity of basal ganglia subdivisions would be associated with




Patients with PD were recruited from the Transeuro programme
cohort (FP7 EC http://www.transeuro.org.uk/). All had a diagnosis of
idiopathic PD in accordance with Queen Square Brain Bank criteria
(Lees et al., 2009). A total of thirty-four patients with PD (PDBL) com-
pleted 11C-PE2I PET, structural MRI and resting-state fMRI scans at
baseline, however four were excluded from the current analyses due to
significant head motion. Of these, twenty PD patients completed follow-
up measures after an interval of 19.9 ± 3.8 months, hereby referred to
as the PD follow-up subgroup (PDFU). From this group, three patients
were excluded due to severe signal loss, and two patients were excluded
due to excessive head motion during resting-state fMRI. Therefore, a
total of fifteen patients were included in the longitudinal analysis.
Motor severity was assessed by two experienced clinicians using the
motor sub-score of the Unified Parkinson’s Disease Rating Scale
(UPDRS-part III) (Goetz et al., 2008) and the Hoehn and Yahr staging
scale (Hoehn and Yahr, 1967) whilst they were in an “off” medication
state. We further subdivided the UPDRS-part III into tremor and bra-
dykinesia-rigidity sub-scores. A total of fifteen age- and gender-matched
healthy controls completed structural MRI and resting-state fMRI scans
at baseline. None of the participants scored < 26 on the Mini-Mental
State Examination (MMSE), had atypical or secondary Parkinsonism, or
were ineligible for MRI and PET scanning (claustrophobia, metallic
implants, pregnancy or breastfeeding, recent exposure to ionising ra-
diation). All participants gave written informed consent in accordance
with the Declaration of Helsinki. All aspects of the study were approval
from the appropriate research ethics committees of the UK (REC 12/EE/
0096 & 10/H0805/73) and Sweden (EPN 2013/758 & IK 2013/685)
National Research Ethics Service Committee.
2.2. Image acquisition
All scans were conducted at the Invicro Imaging Centre
(Hammersmith Hospital Campus, London). During scans, participants
were positioned supine; head movement was minimised using memory
foam padding and video monitoring utilised to aid detection and sub-
sequent repositioning.
MRI scans were performed on a 3T Siemens Magnetom Trio with 32-
channel phased-array head coil. High resolution structural images were
acquired using a 3-dimensional T1-weighted sagittal magnetization-
prepared rapid gradient-echo sequence (MPRAGE: TR/TE = 2300/
2.98 ms; TI = 900 ms; FA = 9°; bandwidth = 240 Hz/Px; GRAPPA
acceleration factor = 2; slice thickness = 1 mm (no gap);
FoV = 240 × 256 mm; matrix size = 240 × 256) in which one whole
brain volume was obtained consisting of 160 slices lasting 301 s.
Resting-state fMRI scans were acquired for 368 s using a T2*-weighted
single-shot gradient-echo echo planar imaging (EPI) sequence (TR/
TE = 2500/31.3 ms; FA = 80°; bandwidth = 2298 Hz/Px; GRAPPA
acceleration factor = 2; slice thickness = 3 mm (no gap);
FoV = 192 × 192 mm; matrix size = 64 × 64). 144 brain volumes
were obtained per individual, each consisting of 45 interleaved axial
slices acquired parallel to the AC-PC line. Participants were instructed
to remain as still as possible with their eyes closed, and to avoid falling
asleep during the scan.
11C-PE2I (N-(3-iodopro-2E-enyl)-2β-carbomethoxy-3β-(4′-methyl-
phenyl)nortropane) PET imaging was conducted on a Siemens Biograph
TruePoint HI-REZ 6 PET/CT system. Radioligand volumes (11C-
PE2I = 350 MBq) were prepared to 10 ml using saline solution and
administered intravenously as single bolus injections followed im-
mediately by 10 ml saline flush. Administration was at 1 ml/sec.
Dynamic emission data were acquired continuously for 90 min post-
injection then reconstructed into 26 temporal frames using a filtered
back-projection algorithm (direct inversion Fourier transform; matrix
size = 128x128, zoom = 2.6, 5 mm transaxial Gaussian filter, pixel
size = 2 mm isotropic). A low-dose CT transmission scan (0.36 mSv)
was acquired for attenuation correction prior to the injection of 11C-
PE2I. PD patients were instructed to withdraw their dopaminergic
medication at least 24 h prior to scanning for standard release pre-
parations and 48 h for prolonged release medications (Li et al., 2017).
2.3. Image preprocessing
Standard image preprocessing of resting-state fMRI was performed
using Statistical Parametric Mapping (SPM12, Wellcome Trust Centre
for Neuroimaging, London, UK, http://www.fil.ion.ucl.ac.uk/spm/).
Each participant’s structural image was segmented for cerebrospinal
fluid (CSF) and white matter (WM). Resting-state fMRI data were slice-
time corrected, realigned to the first image using rigid-body motion
transforms and co-registered to the structural image. For every time
point t, the framewise displacement (FD) was calculated, and every
time point that exceeded a pre-defined head motion limit (FD
(t) > 0.5 mm) was removed (Power et al., 2012). The FD values were
later used as nuisance regressors and confounding covariates in the
individual and group-level analyses, respectively. Then, a ‘scrubbing’
procedure was performed using the ‘fsl_motion_outliers’ tool in FSL to
remove the time points affected by head motion (motion spike) (Power
et al., 2012). A nuisance regression was conducted using a Volterra
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series expansion (i.e. Friston 24-parameter model) of the motion esti-
mates (six motor parameters, six motion parameters one time point
before, and the 12 corresponding squared items) (Friston et al., 1996),
the time series of CSF and WM, the motion spike and FD values as
regressors. The structural image was then spatially normalized to a
Montreal Neurological Institute (MNI) space (Mazziotta et al., 1995)
using affine registration followed by non-linear transformation. The
estimated warps were then applied to the corresponding noise-cor-
rected functional images for each participant and smoothed with a 6-
mm full-width-at-half-maximum (FWHM) Gaussian filter. A temporal
band-pass filtering of 0.009 Hz < f < 0.08 Hz was applied to the time
series data to reduce the effects of low-frequency drift and high-fre-
quency noise (Lowe et al., 1998; Fair et al., 2007).
PET and corresponding structural images were preprocessed and
analyzed using MIAKATTM v3.4.2. (Molecular Imaging and Kinetic
Analysis Toolbox, Imanova Ltd., London) (Gunn et al., 2016), which
implements FSL (FMRIB Image Analysis Group, Oxford, UK) (Jenkinson
et al., 2012), SPM and in-house preprocessing and kinetic modelling
procedures. Structural images were brain extracted, segmented and
rigid body registered to the MNI template. Dynamic PET images were
corrected for intra scan head movement using frame-to-frame rigid
registration with a pre-specified reference frame (frame = 16). Rea-
ligned frames between 10 and 90 min were summed to obtain signal
averaged (ADD) images, which were co-registered to the corresponding
structural image. These co-registration matrices were then applied to
the realigned dynamic PET frames and region-of-interest (ROI) maps
overlaid to generate regional time-activity curves (TACs). Regional non-
displaceable binding potential (BPND) was calculated using the simpli-
fied reference tissue model (SRTM) (Lammertsma and Hume, 1996).
Cerebellar grey matter was used as a reference region under the as-
sumption that it has negligible DAT density (Hall et al., 1999; Halldin
et al., 2003).
Striatal ROIs were manually segmented for each participant on
structural MR images displayed in standard space using ROI tools in
Analyze11.0 (Biomedical Imaging Resource, Mayo Clinic). Striatal ROIs
were defined bilaterally in the (i) caudate; (ii) anterior putamen; and
(iii) posterior putamen on the axial plane followed by trace checks on
the coronal plane. The putamen was subdivided into anterior and
posterior parts using a marker placed on the coronal plane at the level
of the anterior commissure (Tziortzi et al., 2011). Substantia nigra and
cerebellar ROIs were obtained from the CIC atlas (CIC Atlas v2.0;
GlaxoSmithKline, Clinical Imaging Centre, London, UK) (Fig. 1). Rigid-
body registration parameters were applied to the grey and white matter
segmentation images to enable automatic masking of cerebellar grey
matter.
2.4. Functional connectivity analysis
Resting-state functional connectivity was assessed using a seed-
based approach with bilateral caudate, anterior putamen, posterior
putamen and substantia nigra as seeds. Functional connectivity maps
were obtained by computing the Pearson’s correlation coefficient be-
tween the averaged time series of each seed region and that of all other
voxels in the brain for each individual participant. These correlation
coefficients were converted to normally distributed values using
Fisher’s r-to-Z transform for use at the group level. The individual z-
maps were entered into a random effect one-sample t-test to identify
brain regions showing significant positive correlations with the seed
ROIs. Then, the individual z-maps were entered into a random effect
two-sample t-test to identify differences in functional connectivity be-
tween groups (PDBL vs. healthy controls at baseline; PDBL vs. PDFU).
Statistical maps were thresholded at voxel-level pFWE < 0.05 and
cluster-level pFDR < 0.05.
2.5. Multiple regression analysis
For patients with PD at baseline (n = 30), to investigate the asso-
ciations between regional 11C-PE2I BPND and functional connectivity of
the seed regions, voxel-based multiple regression analysis was con-
ducted using functional connectivity maps as the dependent variable,
the regional 11C-PE2I BPND as the independent variable, and age/
gender as nuisance covariates. The FD, averaged across the entire time
series, was also entered as a covariate to minimize the potential effect of
motion-related variance on group inference. The correlation analysis
was assessed using t-statistics. To explore correlates of functional con-
nectivity with disease severity, multiple regression analysis was per-
formed with UPDRS-III, bradykinesia-rigidity and tremor sub-scores
entered as covariates of interest. All statistical maps were thresholded
at voxel-level p < 0.001 uncorrected and cluster-level false discovery
rate corrected pFDR < 0.05.
We also assessed how changes in functional connectivity over time
correlated with changes in 11C-PE2I BPND over time. Difference func-
tional connectivity maps were created by voxel-based subtraction (Δ:
follow-up – baseline) and entered into a multiple regression analysis as
the dependent variable with Δ11C-PE2I BPND as the independent vari-
able (Supplementary Material Table 1 provides information on per-
centage annual decrease in regional 11C-PE2I BPND for the PDFU sub-
group), and age at baseline and gender as nuisance covariates. In
addition, to examine how changes in functional connectivity correlated
with changes in motor disability over time, multiple regression analysis
was also performed with ΔUPDRS-III, Δbradykinesia-rigidity and
Δtremor sub-scores entered as covariates of interest. All statistical maps
Fig. 1. Seeds region-of-interest defined in a re-
presentative PD patient. Region-of-interests were
manually segmented for each participant’s on struc-
tural image displayed in standard space. Brain left is
shown on the image left. Four seeds region-of-interest
were defined in each subject: caudate (a, in red),
anterior putamen (a, in yellow), posterior putamen
(a, in blue) and substantia nigra (b, in green). (For
interpretation of the references to colour in this
figure legend, the reader is referred to the web ver-
sion of this article.)
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were thresholded at voxel-level p < 0.001 uncorrected and cluster-
level false discovery rate corrected pFDR < 0.05.
3. Results
Demographics and clinical characteristics of the study participants
are summarised in Table 1.
3.1. Resting-state functional connectivity in patients with PD and healthy
controls
Resting-state functional connectivity of basal ganglia subdivisions at
baseline in patients with PD was generally consistent with previous
studies (Fig. 2). The caudate was connected to the anterior/posterior
cingulate cortex and thalamus. The anterior putamen and posterior
putamen exhibited similar patterns of functional connectivity with the
supplementary motor area (SMA), sensorimotor cortex, thalamus and a
contiguous region of grey matter extending from the thalamus through
the midbrain, pons and cerebellum. The substantia nigra showed
functional connectivity with the caudate, putamen, globus pallidus,
thalamus and cerebellum. The functional connectivity patterns of the
healthy controls were roughly similar to that of the PD patients
(Supplementary Material Fig. 1). To ensure that group-level results
were not influenced by spurious correlations as a result of in-scanner
head movement, we compared the mean FD between the groups
(healthy controls vs. PD at baseline, p = 0.577; PD at baseline vs. PD at
follow up, p = 0.493), suggesting that head movement did not differ-
entially alter resting-state functional connectivity across groups
(Supplementary Material Table 2).
At baseline, voxel-based comparisons of functional connectivity
maps for each of the four seed regions between PD patients and healthy
controls were conducted. Both the caudate and the anterior putamen
showed decreased intraregional functional connectivity for the PD
group as compared to HC (Fig. 3a and 3b), while the posterior putamen
showed the opposite pattern. In the PD group, the posterior putamen
exhibited an enhanced intraregional functional connectivity
intermediate between anterior and posterior putamen (Fig. 3c). PD
patients exhibited reduced functional connectivity between the sub-
stantia nigra and the thalamus and pallidum as well as with smaller
clusters located within the caudate and putamen (Fig. 3d).
Functional connectivity maps of each of the four seed regions were
also compared between baseline and follow-up for the PD patients. We
found a time-related decrease of functional connectivity between the
anterior putamen and sensorimotor cortex (Fig. 4a). In addition, the
posterior putamen showed decreased functional connectivity with the
anterior putamen and the posterior putamen (intraregional), as well as
smaller clusters in the caudate, thalamus and midbrain (Fig. 4b). There
were no significant differences in caudate and substantia nigra func-
tional connectivity between the two time points.
3.2. Correlation between basal ganglia functional connectivity and 11C-
PE2I BPND and clinical measures: multiple regression analyses
At baseline, voxel-based multiple regression analysis of posterior
putamen functional connectivity maps revealed clusters in the midbrain
and pallidum showing a significant positive correlation with posterior
putamenal 11C-PE2I BPND (Fig. 5a, Table 2). No significant correlations
between functional connectivity maps of other seed regions (caudate,
anterior putamen and substantia nigra) and 11C-PE2I BPND values were
observed. Furthermore, we did not find any significant correlations
between the functional connectivity of basal ganglia subdivisions and
clinical scores.
Longitudinally, voxel-based analysis of the change in posterior pu-
tamen functional connectivity (Δ: follow-up – baseline) revealed clus-
ters showing significant positive correlations with Δ11C-PE2I BPND in
the posterior putamen. These clusters were found in the left thalamus
and a contiguous region of grey matter extending from the thalamus,
through the midbrain, as well as in the SMA, precentral gyrus and
postcentral gyrus (Fig. 5b, Table 2). Furthermore, clusters showing
significant positive correlations between Δposterior putamen functional
connectivity and Δbradykinesia-rigidity sub-scores were found in the
right posterior putamen (Fig. 5c, Table 2). No other significant results
Table 1
Demographic and clinical information for all study participants at baseline (PD: n = 30; HC: n = 15) and for the PD subgroup at baseline and 19.9 ± 3.8 months
follow-up (PDFU: n = 15). Independent-samples t-test was used to assess the difference between PD and healthy controls at baseline. For the PD follow-up group,
Wilcoxon signed-rank and paired-samples t-test were used to assess the difference between baseline and follow-up.
Baseline: PD (n = 30); HC (n = 15)
PD HC Statistic p
Gender (M:F) 24:6 8 : 7
Age (years) a 55.4 ± 7.1 53.15 ± 11.4 t(19.674) = 0.696 0.494
Disease duration (years) a 5.8 ± 2.2 N/A
UPDRS-III a 31.3 ± 10.6 N/A
UPDRS-III Bradykinesia-Rigidity a 22.4 ± 8.1 N/A
UPDRS-III Tremor a 6.2 ± 5.3 N/A
Hoehn & Yahr Scale b 2.0 (0.0) N/A
LED a 670.3 ± 361.8 N/A
Follow-Up: PDFU (n = 15)
Baseline Follow-Up Statistic p
Gender (M:F) 12:3 12:3
Age (years) a 53.0 ± 7.2 54.7 ± 7.1 t(14) = 26.445 < 0.001 *
Disease duration (years) a 6.0 ± 2.2 7.7 ± 2.0 t(14) = 26.234 < 0.001 *
UPDRS-III a 31.4 ± 12.0 35.9 ± 10.9 t(14) = 2.003 0.065
UPDRS-III Bradykinesia-Rigidity a 22.4 ± 9.6 25.2 ± 8.9 t(14) = 1.925 0.075
UPDRS-III Tremor a 6.9 ± 4.5 8.3 ± 4.2 t(14) = 1.514 0.152
Hoehn & Yahr Scale b 2.0 (0.0) 2.0 (0.0) Z = 1.7 0.083
LED a 771.7 ± 386.5 906.3 ± 235.7 t(14) = 2.156 0.046 *
a Data are presented as Mean ± SD.
b Data are presented as Median (Interquartile Range).
* Indicates p < 0.05
LED = L-dopa equivalent dose (mg).
UPDRS = Unified Parkinson’s disease rating scale.
The UPDRS and H&Y scale were assessed in the practically defined off-medication state.
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were found for longitudinal analyses.
4. Discussion
Our findings demonstrate that resting-state functional connectivity
of the posterior putamen is associated with the integrity of the dopa-
minergic system in patients with PD. PD patients with more severe
dopaminergic deficits showed larger decreases in posterior putamen
functional connectivity with the midbrain and pallidum. In addition,
longitudinal comparison between the two timepoints revealed that
patients with PD showed reduced functional connectivity of the pos-
terior putamen with the thalamus and midbrain. These functional
connectivity changes were correlated with dopamine deficits of disease
progression. Lastly, increased motor disability was associated with
lower intraregional functional connectivity of the posterior putamen.
These results suggest an essential role of dopamine in striatal function
Fig. 2. Resting-state functional connectivity of basal ganglia subdivisions (a) caudate, (b) anterior putamen, (c) posterior putamen and (d) substantia nigra in patients
with PD. All statistical maps (pFWE < 0.05 FWE-corrected at voxel-level, and pFDR < 0.05 FDR-corrected at cluster-level) are overlaid on a T1-weighted MNI
template. L, left; R, right.
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and demonstrate that resting-state functional connectivity of basal
ganglia subdivisions is compromised by the dopaminergic pathology of
PD.
A previous study using resting-state fMRI demonstrated reduced
functional connectivity within the basal ganglia of patients with early
PD as compared to patients with Alzheimer’s disease (AD) and healthy
controls (Rolinski et al., 2015). These changes were not seen in AD
patients, suggesting that aberrant functional connectivity within the
Fig. 3. Group differences in resting-state functional connectivity between PD patients and healthy controls (HC) (a) caudate, (b) anterior putamen, (c) posterior
putamen and (d) substantia nigra. Blue and red colours represent HC > PD and PD > HC, respectively. All statistical maps (pFWE < 0.05 FWE-corrected at voxel-
level, and pFDR < 0.05 FDR-corrected at cluster-level) are overlaid on a T1-weighted MNI template. L, left; R, right. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
W. Li, et al. NeuroImage: Clinical 28 (2020) 102409
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basal ganglia of PD patients is disease specific. In the current study,
reduced intraregional functional connectivity of the caudate and the
anterior putamen was found in PD patients compared to healthy con-
trols. In contrast, we found increased intraregional functional con-
nectivity of the posterior putamen, suggesting a compensatory me-
chanism that develops in response to marked dopamine decline in the
posterior putamen (Helmich et al., 2010). It has been demonstrated that
noradrenaline, serotonin and acetylcholine are also affected in PD, al-
though to a lesser degree than dopamine, thus it is possible that other
neurotransmitter systems might play a role in mediating changes in
basal ganglia functional connectivity patterns (Shine et al., 2019).
Lastly, we found reduced substantia nigra functional connectivity with
the thalamus extending to the caudate and putamen, which is generally
consistent with results reported by Wu et al. (2012) who also showed
additional reductions to the globus pallidus, insula and SMA in PD
patients as compared to the healthy controls (Wu et al., 2012).
Previous studies have demonstrated significant correlations be-
tween motor symptomatology and altered functional connectivity of
basal ganglia subdivisions in patients with PD (Wu et al., 2009; Hacker
et al., 2012; Agosta et al., 2014). Greater severity of UPDRS-III motor
scores appears to be associated with reduced functional connectivity
between the striatum and midbrain (Hacker et al., 2012) and increased
functional connectivity between the putamen and occipital/parietal
cortex (Agosta et al., 2014), suggesting a potential role basal ganglia
functional connectivity alterations in the occurrence of motor impair-
ment (Cerasa et al., 2016). However, in the current study, baseline
functional connectivity did not correlate with any clinical measures of
motor severity. In line with our findings, a study examined functional
connectivity within the basal ganglia network also did not find any
significant correlations between the basal ganglia network connectivity
and clinical measures (Szewczyk-Krolikowski et al., 2014). They sug-
gested that functional connectivity alterations of basal ganglia network
may be a trait biomarker of PD, reflecting a constitutional fault of the
network and not the resulting motor symptoms (Szewczyk-Krolikowski
et al., 2014).
Postmortem and neuroimaging studies have demonstrated that the
posterior putamen suffers most from degeneration of the nigrostriatal
dopaminergic pathway (Kish et al., 1988; Nurmi et al., 2001; Bruck
et al., 2006; Helmich et al., 2010). The most consistent finding across
resting-state fMRI studies in patients with PD appears to be a reduction
of posterior putamenal functional connectivity that correlates with
greater motor impairment (Herz et al., 2014). Few studies have ex-
amined how striatal functional connectivity varies with dopaminergic
deficit in PD. One study found that reduced functional connectivity
between the putamen and the midbrain was related to dopaminergic
status in the striatum (Rieckmann et al., 2015) while another demon-
strated that functional connectivity was modulated by striatal dopa-
mine levels (Baik et al., 2014). Here, in thirty PD patients, we found
that reduced functional connectivity between the posterior putamen
and the midbrain was significantly associated with dopamine levels in
the posterior putamen. In a preliminary analysis, we also found in a
subset of fifteen PD patients that changes in this functional connectivity
pattern correlated with changes in dopamine levels in the posterior
putamen. Taken together, these findings suggest that resting-state
functional connectivity of the posterior putamen may reflect impair-
ment of the nigrostriatal dopaminergic projection in the PD brain.
Although PD is the most common form of parkinsonism, there are
other atypical neurodegenerative conditions that mimic the clinical
features of PD, such as multiple system atrophy (MSA) and progressive
supranuclear palsy (PSP) (Politis, 2014). DAT radioligands with PET
have shown promising sensitivity and specificity for distinguishing
patients with parkinsonian syndromes from healthy controls (Antonini
et al., 2001; Jakobson Mo et al., 2018). However, dopamine-specific
radioligands cannot accurately differentiate between PD, MSA and PSP.
Advanced MRI techniques, such as resting-state fMRI and arterial spin
labeling (ASL), may therefore help to provide complementary in-
formation for more accurate differential diagnosis. Recently developed
hybrid PET/MR systems allow simultaneous acquisition of MRI and PET
data, which in theory enables more precise spatial co-registration and
importantly offers greater convenience for motor impaired patients
(Tondo et al., 2019). Indeed, combined acquisition of ASL and 18F-FDG
PET on a hybrid PET/MR system was recently shown to increase sen-
sitivity in differentiating PD and MSA, based on changes in the caudate
nucleus, pons and cerebellum (Ruan et al., 2019). Another study de-
monstrated a close relationship between global grey matter changes
and the degeneration of striatal dopaminergic circuits in patients with
PD (Choi et al., 2016). Taken together, as a non-invasive and more
comprehensive approach, the combined use of advanced MRI and PET
on hybrid scanners may play an increasingly important role for evalu-
ating the underlying mechanisms of patients with PD.
This study has some limitations that need to be addressed. First,
although our longitudinal results accord with well-founded predictions
they were based on a relatively small number of PD participants and as
such should be validated in larger samples. We believe that our findings
provide promising new insights into changes in resting-state functional
connectivity and their relation to DAT decline and motor dysfunction in
PD patients. Second, only a single time interval of ~ 20 months was
studied, thus future resting-state fMRI studies should be designed to
evaluate patients more than twice and at longer intervals, which may
provide additional evidence on the staging of PD progression and the
Fig. 4. Changes in resting-state functional con-
nectivity in patients with PD between two
timepoints (a) anterior putamen and (b) pos-
terior putamen. Blue colour represents the de-
creased functional connectivity of PD patients at
follow-up compared to baseline. All statistical
maps (pFWE < 0.05 FWE-corrected at voxel-
level, and pFDR < 0.05 FDR-corrected at cluster-
level) are overlaid on a T1-weighted MNI tem-
plate. L, left; R, right. (For interpretation of the
references to colour in this figure legend, the
reader is referred to the web version of this ar-
ticle.)
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Fig. 5. Results of the voxel-based multiple regression analysis for PD patients at baseline (n = 30; a) and follow-up (n = 15; b and c). (a) The posterior putamen
functional connectivity revealed clusters in the midbrain and pallidum, that showed a significant positive correlation with 11C-PE2I BPND in the posterior putamen.
(b) Changes in posterior putamen 11C-PE2I-BPND are positively correlated with changes in functional connectivity between the posterior putamen and thalamus,
midbrain, SMA, precentral gyrus and postcentral gyrus. (c) Changes in bradykinesia-rigidity sub-score are positively correlated with changes in posterior putamen
intraregional functional connectivity. All statistical maps (p < 0.001 uncorrected at voxel-level, and pFDR < 0.05 FDR-corrected at cluster-level) are overlaid on a
T1-weighted MNI template. L. left; R, right.
Table 2
Clusters showing positive correlations between posterior putamen functional connectivity and 11C-PE2I BPND and disease severity (Bradykinesia-Rigidity sub-score),
as revealed by voxel-wise multiple regression analysis for all PD patients. Longitudinal multiple regression using difference maps (Δ: follow-up – baseline) from the
PDFU group are also shown.
Seed Covariate of Interest Cluster Peak T MNI Coordinates Brain Region
p Value* k x y z
Posterior putamen Baseline Analysis(n = 30) 11C-PE2I BPND 0.027 22 4.65 0 −18 −12 Midbrain
Follow-up Analysis(n = 15) Δ 11C-PE2I BPND 0.007 580 5.37 −4 −26 −8 Midbrain, extending into thalamus
0.001 845 4.66 10 −4 72 Supplementary motor area




0.032 48 6.37 24 6 −10 Posterior putamen
Threshold of p < 0.001 uncorrected at voxel-level and p < 0.05 corrected for false discovery rate at cluster-level.
Coordinates of peak voxels (x, y, z) are given in Montreal Neurologic Institute (MNI) space.
*Indicates correction for false discovery rate.
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relevance to dopaminergic deficit. Third, the current study did not
control for the potential impact of PD-related atrophy on dopaminergic
deficits and resting state functional connectivity. Previous studies in PD
have shown a close relationship between atrophy and the degeneration
of striatal dopaminergic circuits (Choi et al., 2016), but have failed to
find an association with disruptions of functional connectivity (Helmich
et al., 2010; Luo et al., 2014). Lastly, patients with PD in this study
underwent scanning while in the practically-defined “off” medicated
state, but the long-term impact of chronic dopaminergic treatment on
resting-state functional connectivity still remains unclear and as such
warrants further investigation in future studies.
5. Conclusion
In conclusion, our study demonstrates that functional connectivity
of basal ganglia subdivisions in PD is closely related to both the in-
tegrity of the dopaminergic system and motor severity. Our findings
suggest that basal ganglia functional connectivity in the resting-state
may be a powerful imaging biomarker for assessing underlying PD
pathology and its progression, and may offer a meaningful way to in-
vestigate the mechanisms whereby dopamine deficiency leads to motor
symptoms.
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